Background The US government proposes pandemic influenza mitigation guidance that includes isolation and antiviral treatment of ill persons, voluntary household member quarantine and antiviral prophylaxis, social distancing of individuals, school closure, reduction of contacts at work, and prioritized vaccination. Is this the best strategy combination? Is choice of this strategy robust to pandemic uncertainties? What are critical enablers of community resilience? Methods and Findings We systematically simulate a broad range of pandemic scenarios and mitigation strategies using a networked, agent-based model of a community of explicit, multiply-overlapping social contact networks. We evaluate illness and societal burden for alterations in social networks, illness parameters, or intervention implementation. For a 1918-like pandemic, the best strategy minimizes illness to <1% of the population and combines network-based (e.g. school closure, social distancing of all with adults' contacts at work reduced), and case-based measures (e.g. antiviral treatment of the ill and prophylaxis of household members). We find choice of this best strategy robust to removal of enhanced transmission by the young, additional complexity in contact networks, and altered influenza natural history including extended viral shedding. Administration of age-group or randomly targeted 50% effective pre-pandemic vaccine with 7% population coverage (current US H5N1 vaccine stockpile) had minimal effect on outcomes. In order, mitigation success depends on rapid strategy implementation, high compliance, regional mitigation, and rigorous rescinding criteria; these are the critical enablers for community resilience. Conclusions Systematic evaluation of feasible, recommended pandemic influenza interventions generally confirms the US community mitigation guidance yields best strategy choices for pandemic planning that are robust to a wide range of uncertainty. The best strategy combines network- and case-based interventions; network-based interventions are paramount. Because strategies must be applied rapidly, regionally, and stringently for greatest benefit, preparation and public education is required for long-lasting, high community compliance during a pandemic.
References
[1]
Ciofi degli Atti ML, Merler S, Rizzo C, Ajelli M, Massari M, et al. (2008) Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS ONE 3: e1790.
[2]
Epstein JM, Goedecke DM, Yu F, Morris RJ, Wagener DK, et al. (2007) Controlling pandemic flu: the value of international air travel restrictions. PLoS One e401.
[3]
Halloran ME, Ferguson NM, Eubank S, Longini IM Jr, Cummings DAT, et al. (2008) Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A 105: 4639–4644.
[4]
McCaw JM, McVernon J (2007) Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math Biosci 209: 336–360.
[5]
Riley S, Wu JT, Leung GM (2007) Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate. PLoS Med 4: e218.
[6]
Roberts MG, Maker M, Jennings LC, Sertsou G, Wilson N (2007) A model for the spread and control of pandemic influenza in an isolated geographic region. J R Soc Interface 4: 325–330.
[7]
Wu JT, Riley S, Fraser C, Leung GM (2006) Reducing the impact of the next influenza pandemic using household-based public health interventions. PLOS Med 3: e361.
[8]
Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209–214.
[9]
Longini IM Jr, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, et al. (2005) Containing pandemic influenza at the source. Science 309: 1083–1087.
[10]
Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, et al. (2006) Strategies for mitigating an influenza pandemic. Nature 442: 448–452.
[11]
Germann TC, Kadau K, Longini IM Jr, Macken CA (2006) Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A 103: 5935–5940.
[12]
Davey VJ, Glass RJ (2008) Rescinding community mitigation strategies in an influenza pandemic. Emerg Infect Dis 14: 365–372.
[13]
Glass RJ, Glass LM, Beyeler W (2005) Local mitigation strategies for pandemic influenza. National Infrastructure Simulation & Analysis Center, Sandia National Laboratories, SAND2005-7955J. Available: http://www.sandia.gov/nisac/docs/NISAC_F？luMitigationPaperWithFullSOMTables.doc Accessed 2008 Apr 21.
[14]
Glass RJ, Glass LM, Beyeler WE, Min HJ (2006) Targeted social distancing design for pandemic influenza. Emerg Infect Dis 12: 1671–1681.
[15]
Centers for Disease Control and Prevention (2007) Interim Pre-Pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States–Early, Targeted, Layered Use of Nonpharmaceuticial Interventions. Available: http://www.pandemicflu.gov/plan/communit？y/community_mitigation.pdf Accessed 2008 Jan 13.
[16]
Glass RJ, Min J, Beyeler WE, Glass LM (2007) Design of community containment for pandemic influenza with Loki-Infect. National Infrastructure Simulation & Analysis Center, Sandia National Laboratories, SAND2007-1184P. Available: http://www.sandia.gov/nisac/docs/MatrixR？eport/RJGMatrixReport.doc Accessed 2007 Oct 29.
[17]
Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, et al. (2007) Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 28: 1071–1076.
[18]
Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza (H5N1) Virus (2008) Update on avian influenza A (H5N1) virus infection in humans. NEJM 358: 261–273.
[19]
Glass LM, Glass RJ (2008) Social contact networks for the spread of pandemic influenza in children and teenagers. BMC Public Health 8: 61. doi:10.1186/1471-2458-8-61.
[20]
Homeland Security Council (2007) National Strategy for Pandemic Influenza: Implementation Plan, One Year Summary. Available: http://www.whitehouse.gov/homeland/nspi_？oneyear.pdf Accessed 2008 Apr 21.
[21]
Department of Health and Human Services (2006) HHS pandemic influenza plan, supplement 6, vaccine distribution and use. Available: http://www.hhs.gov/pandemicflu/plan/sup6？.html#S6-II Accessed 2008 Jan 9.
[22]
Diekmann O, Heesterbeek JAP (2000) Mathematical Epidemiology of Infectious Diseases. Simon L, editor. Chichester, West Sussex, England: Wiley.
[23]
Mills CE, Robins JM, Lipsitch M (2004) Transmissibility of 1918 pandemic influenza. Nature 432: 904–906.
[24]
Bootsma MC, Ferguson NM (2007) The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A 104: 7588–7593.
[25]
Committee on Modeling Community Containment for Pandemic Influenza (2006) Modeling Community Containment for Pandemic Influenza: A Letter Report. Board on Population Health and Public Health Practice, Institute of Medicine, The National Academies Press. Available: http://www.nap.edu/catalog/11800.html Accessed 2008 Apr 11.
[26]
Hatchett RJ, Mecher CE, Lipsitch M (2007) Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci U S A 104: 7582–7587.
[27]
Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, et al. (2007) Nonpharmaceutical interventions implemented by US cities during the 1918–1919 influenza pandemic. JAMA 298: 644–654.
[28]
Centers for Disease Control and Prevention (2005) Interventions to increase influenza vaccination of health-care workers–California and Minnesota. MMWR 54: 196–199.
[29]
De Jong MD, Thanh TT, Kahn TH (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. NEJM 353: 2667–2672.
[30]
Hurt AC, Ho HT, Barr I (2006) Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert Rev Anti Infect Ther 4: 795–805.
[31]
Hurt AC, Selleck P, Komadina N, Shaw R, Brown L, et al. (2007) Susceptibility of highly pathogenic A (H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res 73: 228–231.
[32]
Lipsitch M, Cohen T, Murray M, Levin BR (2007) Antiviral resistance and the control of pandemic influenza. PLoS Med 4: 0111–0121.
[33]
McKimm-Breschkin JL, Selleck PW, Usman TB, Johnson MA (2007) Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis 9: 1354–1357.
[34]
Meltzer MI (2008) Pandemic influenza, reopening schools, and returning to work. Emerg Infect Dis 14: 509–510.
